BioCardia, Inc. (BCDA) insider trading
BioCardia, Inc. insiders have made 3 open-market purchases worth $4k since Sep 24, 2026, by 1 insider. The latest: Peter Altman (President) bought $475, filed Oct 20, 2026, scored 26 out of 100. The biggest: $2k by Peter Altman, filed Sep 24, 2026.
Follow BCDA, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 20 Form 4 (opens sec.gov) |
Peter AltmanPresidentPresident · Penny stock: hard to trade | +0% stake | 26 | $475 500 at $0.95 |
— | — |
| Sep 30 Form 4 (opens sec.gov) |
Peter AltmanPresidentPresident · Penny stock: hard to trade | +0% stake | 26 | $1k 1,000 at $1.03 |
— | — |
| Sep 24 Form 4 (opens sec.gov) |
Peter AltmanPresidentPresident · Penny stock: hard to trade | +1% stake | 26 | $2k 1,900 at $1.05 |
— | — |
Insiders who bought BCDA
- Peter Altman President
Questions
Are insiders buying BCDA stock?
Yes. In the last 90 days, 3 open-market purchases were filed, worth $4k.
Who bought BCDA stock most recently?
Peter Altman, President, bought 500 shares for $475 (Form 4 (opens sec.gov), filed Oct 20, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 20, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer